Trikafta and Azelastine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Trikafta (elexacaftor, ivacaftor, tezacaftor; ivacaftor) and Azelastine (azelastine hydrochloride). Common drug interactions include dehydration among females and nausea among males.
The phase IV clinical study analyzes what interactions people have when they take Trikafta and Azelastine. It is created by eHealthMe based on reports of 109 people who take the same drugs from the FDA, and is updated regularly.
What is Trikafta?
Trikafta has active ingredients of elexacaftor, ivacaftor, tezacaftor; ivacaftor. eHealthMe is studying from 11,852 Trikafta users. Check the latest studies of Trikafta.
What is Azelastine?
Azelastine has active ingredients of azelastine hydrochloride. It is often used in allergies. eHealthMe is studying from 17,400 Azelastine users. Check the latest studies of Azelastine.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
109 people who take Trikafta and Azelastine together, and have interactions are studied.
What are the common drug interactions of Trikafta and Azelastine, by gender? *
What are the common drug interactions of Trikafta and Azelastine, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Trikafta and Azelastine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Trikafta (11,852 reports)
- Azelastine (17,400 reports)
Browse all drug interactions of Trikafta and Azelastine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Trikafta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Azelastine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Trikafta and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Azelastine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on elexacaftor, ivacaftor, tezacaftor; ivacaftor and azelastine hydrochloride (the active ingredients of Trikafta and Azelastine, respectively), and Trikafta and Azelastine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Doxil and Morphine Sulfate - a second ago
- Could Elmiron cause Muscle Aches? - 3 seconds ago
- Gastroesophageal Reflux Disease and drugs of ingredients of phenazopyridine hydrochloride - 4 seconds ago
- Dyspnea Exacerbated and drugs of ingredients of daratumumab;hyaluronidase-fihj - 4 seconds ago
- Drug interactions of Fluconazole and Plavix - 5 seconds ago
- Videx and Hepatic Failure for Women aged 30-39 - 5 seconds ago
- Drug interactions of Vitamin D and Hydrea - 6 seconds ago
- Drug interactions of Atenolol and Medroxyprogesterone Acetate - 8 seconds ago
- Could Duramorph Pf cause Constipation? - 10 seconds ago
- Zyrtec and Potassium Gluconate drug interactions for women aged 50-59 - 10 seconds ago